Impact of COVID-19 and Post-COVID Syndrome on Osteomyotendinous Injuries: A Scoping Review

Read full text Summarise with VIRAT
Authors: Gabriel Fassina Ladeia, Leonardo Vidal Andreato
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

COVID-19 is a multisystem disease characterized by a wide range of clinical manifestations. Among the most frequently reported symptoms are fatigue, dyspnea, sleep disturbances, as well as muscle and joint pain. In a significant proportion of individuals previously infected with SARS-CoV-2, these symptoms may persist beyond the acute phase. This condition affects approximately 10% to 30% of patients and may last for several months after the initial infection. Additionally, factors such as female sex, older age, smoking, overweight or obesity, the presence of chronic diseases, and a history of hospitalization have been associated with a higher risk of developing Post-COVID-19 Syndrome. The effects of COVID-19 and Post-COVID-19 Syndrome on the musculoskeletal system are not yet fully understood. However, recent studies have reported neurological disturbances and musculoskeletal complications, such as reduced peripheral nerve conduction and loss of muscle mass, as part of the disease manifestations. These alterations directly impact individuals' quality of life, affecting performance in occupational, leisure, and sports activities. Previous evidence indicates that COVID-19 may contribute to changes in muscle thickness and tendon alterations, particularly in individuals who experienced moderate to severe forms of the disease. These changes in musculoskeletal structure may impair force production capacity and, consequently, increase the risk of osteomyotendinous injuries. Similarly, symptoms such as pain, joint stiffness, and arthralgia have been frequently reported both during and after the active phase of the disease, suggesting that, although joint pain may have multifactorial etiologies, it can be exacerbated by SARS-CoV-2 infection. Furthermore, there is evidence that inflammatory processes triggered by the virus may also negatively affect bone health. Despite the growing number of publications on the repercussions of COVID-19, important gaps remain in understanding the magnitude and specific characteristics of osteomyotendinous injuries associated with the infection, both during the acute phase and in Post-COVID-19 Syndrome. In this context, a scoping review is relevant as it allows for the mapping and synthesis of available evidence, helping to identify patterns, limitations, and research opportunities related to the impact of COVID-19 on the occurrence of osteomyotendinous injuries.

Fields of Study & Subjects

Long-Term Effects of COVID-19 COVID-19 Clinical Research Studies Tendon Structure and Treatment

Publication details

Publication date
1 January 2026
Language
EN
Document type
Preprint